HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation.

Abstract
The use of zanamivir in seven patients with influenza (three A and four B) post allograft is described. Inhaled zanamivir (10 mg twice daily) was continued from the diagnosis of influenza until excretion of virus ceased (median duration 15 days, range 5 to 44 days). There was no toxicity attributable to zanamivir and rapid resolution of influenza symptoms was seen. There was no mortality due to influenza in the seven patients. The good outcome of 30 previous patients with influenza post transplant is described. A randomised multicentre study would be required to demonstrate efficacy.
AuthorsA A Johny, A Clark, N Price, D Carrington, A Oakhill, D I Marks
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 29 Issue 2 Pg. 113-5 (Jan 2002) ISSN: 0268-3369 [Print] England
PMID11850704 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antiviral Agents
  • Guanidines
  • Pyrans
  • Sialic Acids
  • Zanamivir
Topics
  • Adolescent
  • Adult
  • Antiviral Agents (adverse effects, therapeutic use)
  • Female
  • Guanidines
  • Hematologic Neoplasms (complications, therapy)
  • Humans
  • Influenza A virus
  • Influenza B virus
  • Influenza, Human (drug therapy, etiology)
  • Male
  • Myelodysplastic Syndromes (complications, therapy)
  • Pyrans
  • Sialic Acids (adverse effects, therapeutic use)
  • Stem Cell Transplantation (adverse effects)
  • Transplantation, Homologous
  • Treatment Outcome
  • Zanamivir

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: